Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-induced nephropathy: A prospective randomized study

Journal of Interventional Cardiology

Volumn 26, Issue 1, 2013, Pages 90-96

  Albabtain, Monirah A ^a   Almasood, Ali ^a   Alshurafah, Hytham ^a   Alamri, Hussain ^a   Tamim, Hani ^b  

^a PRINCE SULTAN CARDIAC CENTER   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIDIABETIC AGENT; ASCORBIC ACID; CONTRAST MEDIUM; CREATININE; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; HEART CATHETERIZATION; HIGH RISK PATIENT; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; CONTRAST MEDIA; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FLUID THERAPY; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84874110117     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2012.00767.x     Document Type: Article

References (30)

1. Al-Ghonaim M, Pannu N,. Prevention and treatment of contrast-induced nephropathy. Tech Vasc Interv Radiol 2006; 9 (2): 42-49. (Pubitemid 46670027)
2. Nash K, Hafeez A, Hou S,. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39 (5): 930-936. (Pubitemid 34454211)
3. McCullough PA, Sandberg KR,. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4 (Suppl 5): S3-S9. (Pubitemid 37526937)
4. Cavusoglu E, Chhabra S, Marmur JD, et al. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 2004; 52 (5): 419-432. (Pubitemid 39457522)
5. Bagshaw SM, Culleton BF,. Contrast-induced nephropathy: Epidemiology and prevention. Minerva Cardioangiol 2006; 54 (1): 109-129. (Pubitemid 43343117)
6. Briguori C, Marenzi G,. Contrast-induced nephropathy: Pharmacological prophylaxis. Kidney Int Suppl 2006;(100): S30-S38.
7. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44 (7): 1393-1399. (Pubitemid 39303939)
8. Ghani AA, Tohamy KY,. Risk score for contrast induced nephropathy following percutaneous coronary intervention. Saudi J Kidney Dis Transpl 2009; 20 (2): 240-245.
9. Mehran R, Nikolsky E,. Contrast-induced nephropathy: Definition, epidemiology, and patients at risk. Kidney Int Suppl 2006;(100): S11-S15.
10. Mueller C,. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int Suppl 2006;(100): S16-S19.
11. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008; 148 (4): 284-294. (Pubitemid 351665489)
12. Zagler A, Azadpour M, Mercado C, et al. N-acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trials. Am Heart J 2006; 151 (1): 140-145. (Pubitemid 41815344)
13. Duong MH, MacKenzie TA, Malenka DJ,. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: Comprehensive meta-analysis. Catheter Cardiovasc Interv 2005; 64 (4): 471-479. (Pubitemid 40463445)
14. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110 (18): 2837-2842. (Pubitemid 39473606)
15. Briguori C, Airoldi F, D'Andrea D, et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 2007; 115 (10): 1211-1217. (Pubitemid 46594764)
16. Boscheri A, Weinbrenner C, Botzek B, et al. Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clin Nephrol 2007; 68 (5): 279-286. (Pubitemid 350047760)
17. Zhou L, Chen H,. Prevention of contrast-induced nephropathy with ascorbic acid. Intern Med 2012; 51 (6): 531-535.
18. Reddan D, Laville M, Garovic VD,. Contrast-induced nephropathy and its prevention: What do we really know from evidence-ased findings ? J Nephrol 2009; 22 (3): 333-351.
19. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41.
20. From AM, Al Badarin FJ, McDonald FS, et al. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: Meta-analysis of randomized, controlled trials. Circ Cardiovasc Interv 2010; 3 (4): 351-358.
21. Van Praet JT, De Vriese AS,. Prevention of contrast-induced nephropathy: A critical review. Curr Opin Nephrol Hypertens 2007; 16 (4): 336-347. (Pubitemid 46944332)
22. Balemans CE, Reichert LJ, van Schelven BI, et al. Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology 2012; 263 (3): 706-713.
23. Katholi RE, Woods WT, Jr., Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 1998; 32 (1): 64-71. (Pubitemid 28311873)
24. Sheridan AM, Bonventre JV,. Pathophysiology of ischemic acute renal failure. Contrib Nephrol 2001;(132): 7-21.
25. Haller C, Hizoh I,. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 2004; 39 (3): 149-154. (Pubitemid 38263921)
26. Tepel M, Zidek W,. Acetylcysteine and contrast media nephropathy. Curr Opin Nephrol Hypertens 2002; 11 (5): 503-506.
27. Naidu KA,. Vitamin C in human health and disease is still a mystery? An overview. Nutr J 2003; 2: 7.
28. Cronin RE,. Contrast-induced nephropathy: Pathogenesis and prevention. Pediatr Nephrol 2010; 25 (2): 191-204.
29. Nallamothu BK, Shojania KG, Saint S, et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004; 117 (12): 938-947. (Pubitemid 40075562)
30. Anderson SM, Park ZH, Patel RV,. Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy. Ann Pharmacother 2011; 45 (1): 101-107.